Inhibition of C-Jun N Terminal Kinase (JNK) Improves Functional Beta Cell Mass in Human Islets and Leads to AKT and Glycogen Synthase Kinase-3 (GSK-3) Phosphorylation

Diabetologia - Germany
doi 10.1007/s00125-007-0889-4

Related search